A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ISIS 546254 for Preventive Treatment of Chronic Migraine
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2017
At a glance
- Drugs IONIS PKKRx (Primary)
- Indications Migraine
- Focus Adverse reactions; Therapeutic Use
- 03 Oct 2017 Status changed from not yet recruiting to recruiting.
- 14 Jun 2017 Planned initiation date changed from 1 May 2017 to 31 Jul 2017.
- 13 Apr 2017 New trial record